{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":310,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-06-08T22:18:30.179389+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos","slug":"building-cell-therapy-companies-with-kenai-therapeutics-nick-manusos","published_at":"2025-12-29T11:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/building-cell-therapy-companies-with-kenai-therapeutics-nick-manusos","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/18401996-building-cell-therapy-companies-with-kenai-therapeutics-nick-manusos.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/18401996-building-cell-therapy-companies-with-kenai-therapeutics-nick-manusos.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell therapy spinouts from FujiFilm Cellular Dynamics, learning from big pharma decision-making processes, and dosing the first patient with Kenai's allogeneic neuron replacement cell therapy for Parkinson's disease. Nick also talks about funding an early-stage cell therapy company and forging key manufacturing...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks a…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2799,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/building-cell-therapy-companies-with-kenai-therapeutics-nick-manusos/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/building-cell-therapy-companies-with-kenai-therapeutics-nick-manusos.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}